Privately-owned Molecular Partners AG of Switzerland has expanded its relationship with Johnson & Johnson Inc with an agreement to research potential products for a number of immunological diseases using its protein technology. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
